Intellia Therapeutics
NTLA
$19.18
Share price
-0.24%
Change (1 day)
-53.70%
Change (1 year)
Intellia Therapeutics (NTLA) - Total liabilities
Total liabilities on the balance sheet as of September 2024 : A$0.32 Billion
According to Intellia Therapeutics's latest financial reports the company's total liabilities are A$0.32 Billion. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Intellia Therapeutics - Total liabilities on balance sheet (from 2015 to 2024)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023-12-31 | A$0.36 B | -11.95% |
| 2022-12-31 | A$0.41 B | 19.24% |
| 2021-12-31 | A$0.35 B | 80.66% |
| 2020-12-31 | A$0.19 B | 111.02% |
| 2019-12-31 | A$91.98 M | -6.62% |
| 2018-12-31 | A$98.5 M | 1.67% |
| 2017-12-31 | A$96.88 M | -21.65% |
| 2016-12-31 | A$0.12 B | -12.83% |
| 2015-12-31 | A$0.14 B | 3611.43% |
| 2014-12-31 | A$3.82 M |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 | A$43.96 M | -86.68% | 🇺🇸 USA |